The nucleoside reverse transcriptase inhibitor abacavir continues to be associated with a near-doubling of the risk of heart attack, according to the latest update from the Data Collection on Adverse events of Anti-HIV Drugs study, presented to the 21st Conference on Retroviruses and Opportunistic Infections this month in Boston.
http://ift.tt/1h0shfc
http://ift.tt/1h0shfc
No comments:
Post a Comment